共 50 条
- [1] TRAF3 Loss-of-Function Reveals the Non-Canonical NF-κb Pathway As a Therapeutic Target in Diffuse Large B-Cell LymphomaBLOOD, 2022, 140 : 2042 - 2043Li, Michael Y.Chong, Lauren C.Woolcock, Bruce W.Telenius, AdeleBen-Neriah, SusanaSlack, Graham W.Lam, VivianJiang, AixiangVigano, ElenaAoki, TomohiroHealy, ShannonKrystal, GeraldVenturutti, LeandroScott, David W.Steidl, Christian
- [2] Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphomaBMC Proceedings, 7 (Suppl 2)Daisuke ItoJaime F Modiano
- [3] Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma:: clinical implicationsHISTOPATHOLOGY, 2008, 53 (04) : 441 - 449Espinosa, I.Briones, J.Bordes, R.Brunet, S.Martino, R.Sureda, A.Sierra, J.Prat, J.
- [4] TRAF3 loss- of- function reveals the noncanonical NF-K B pathway as a therapeutic target in diffuse large B cell lymphomaPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (18)Li, Michael Y.Chong, Lauren C.Duns, GerbenLytle, AndrewWoolcock, BruceJiang, AixiangTelenius, AdeleBen-Neriah, SusanaNawaz, WaqasSlack, Graham W.Elisia, IngridVigano, ElenaAoki, TomohiroHealy, ShannonKrystal, GeraldVenturutti, LeandroScott, David W.Steidl, Christian
- [5] RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphomaAGING-US, 2016, 8 (12): : 3321 - 3340Zhang, MingzhiXu-Monette, Zijun Y.Li, LingManyam, Ganiraju C.Visco, CarloTzankov, AlexandarWang, JingMontes-Moreno, SantiagoDybkaer, KarenChiu, AprilOrazi, AttilioZu, YouliBhagat, GovindRichards, Kristy L.Hsi, Eric D.Choi, William W. L.van Krieken, J. HanHuh, JooryungPonzoni, MaurilioFerreri, Andres J. M.Moller, Michael B.Parsons, Ben M.Winter, Jane N.Piris, Miguel A.Medeiros, L. JeffreyPham, Lan V.Young, Ken H.
- [6] NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphomaFRONTIERS IN ONCOLOGY, 2023, 13Jayawant, EleanorPack, ArranClark, HeatherKennedy, EmmaGhodke, AnkurJones, JohnPepper, ChrisPepper, AndreaMitchell, Simon
- [7] The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphomaBLOOD, 2022, 139 (03) : 384 - 398Eluard, BaptisteNuan-Aliman, StephanieFaumont, NathalieCollares, DaviBordereaux, DidierMontagne, AurelieMartins, IsabelleCagnard, NicolasCaly, MartialTaoui, OussamaLordello, LeonardoLehmann-Che, JacquelineTesson, BrunoMartinez-Climent, Jose-AngelCopie-Bergman, ChristianeHaioun, CorinneTilly, HerveBonsang, BenjaminVincent-Salomon, AnneJais, Jean-PhilippeJardin, FabriceLeroy, KarenMaiuri, Maria ChiaraKroemer, GuidoMolina, Thierry JoFeuillard, JeanBaud, Veronique
- [8] TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax ProteinsFRONTIERS IN MICROBIOLOGY, 2019, 10Fochi, StefaniaBergamo, ElisaSerena, MichelaMutascio, SimonaJourno, ChloeMahieux, RenaudCiminale, VincenzoBertazzoni, UmbertoZipeto, DonatoRomanelli, Maria Grazia
- [9] Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphomaSEMINARS IN CANCER BIOLOGY, 2016, 39 : 26 - 31Pasqualucci, LauraZhang, Baochun
- [10] A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphomaLeukemia, 2021, 35 : 1976 - 1989Hongbo WangWei WeiJing-Ping ZhangZhihui SongYangyang LiWenming XiaoYijun LiuMu-Sheng ZengMichael N. PetrusCraig J. ThomasMarshall E. KadinMasao NakagawaThomas A. WaldmannYibin Yang